Novo Nordisk acquires blood pressure drug for $1.3B : compar

COPENHAGEN: Danish drugmaker Novo Nordisk, which specialises in anti-diabetic and anti-obesity treatments, announced on Monday it is acquiring hypertension drug ocedurenone for $1.3 billion

Related Keywords

Copenhagen , Køavn , Denmark , Manila , Philippines , Danish , , Novo Nordisk , Terms Of Service , Manila Times , Novo , Nordisk , Acquires , Blood , Pressure , Drug , For , P3 3b ,